It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Review Which Crypto Strategies Are Low Risk, focusing on capital preservation, diversification, and disciplined rebalancing.
27,978 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Micron stock losing ground sparks questions about memory cycles, AI-driven demand, and macro risks. This article brea...
What if you had started January with a tech-focused Vanguard ETF? This deep dive explains why a January move into thi...
Bitcoin hovers around 82,000 as traders assess whether the bear market bottom when will be confirmed. A sustained ETF...
Major DeFi protocols are migrating to Chainlink's CCIP after a $292 million KelpDAO exploit, pushing LINK higher as t...
Ripple price action shows early signs of seller exhaustion near a critical support, setting the stage for a potential...
Dogecoin broke through a multi-session resistance with a heavy volume burst, prompting traders to eye the next hurdle...
Bitcoin holds a narrow range around the high $70Ks to near $80K as investors await a decisive breakout. Analysts warn...
Hillary Clinton testifies in New York as part of a House probe into Jeffrey Epstein, with Bill Clinton expected to fo...
Ethereum rebounded from February lows but remains trapped under major moving averages and a descending structure. Thi...
Bitcoin tumbles past a key ascending pattern, pushing toward $60,000 as investors reassess risk. Traders ask where co...
When a major fund manager trims a stake in a top municipal income fund, it sparks questions about risk, yields, and s...